GEODE CAPITAL MANAGEMENT, LLC - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 48 filers reported holding ANGION BIOMEDICA CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$97,093
+71291.9%
167,403
-0.6%
0.00%
Q4 2022$136
-99.9%
168,436
-0.3%
0.00%
Q3 2022$155,000
+56.6%
168,887
+94.2%
0.00%
Q2 2022$99,000
-81.0%
86,947
-64.6%
0.00%
Q1 2022$521,000
-20.0%
245,875
+9.4%
0.00%
Q4 2021$651,000
-73.5%
224,653
-10.8%
0.00%
Q3 2021$2,459,000
+86.6%
251,719
+148.5%
0.00%
Q2 2021$1,318,000
-23.5%
101,290
+6.3%
0.00%
Q1 2021$1,722,00095,3060.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 525,000$599,0000.64%
Nantahala Capital Management 1,131,001$1,289,0000.06%
BVF INC/IL 1,071,297$1,221,0000.06%
Birchview Capital, LP 54,392$62,0000.04%
Knoll Capital Management, LLC 60,000$68,0000.04%
Ground Swell Capital, LLC 16,258$19,0000.04%
LAKE STREET ADVISORS GROUP, LLC 246,904$282,0000.02%
Patriot Financial Group Insurance Agency, LLC 36,500$41,0000.01%
BLB&B Advisors, LLC 56,847$65,0000.01%
Park West Asset Management LLC 75,503$86,0000.01%
View complete list of ANGION BIOMEDICA CORP shareholders